4 ms·
Articles like https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-oxycontin-opioids.html https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-...
by raesene9 6y ago
Articles like https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-oxycontin-opioids.html https://www.nytimes.com/2020/11/27/business/mckinsey-purdue-... have some details.
A quote from that shows some details :-
"
In a 2017 presentation, according to the records, which were filed in court on behalf of multiple state attorneys general, McKinsey laid out several options to shore up sales. One was to give Purdue’s distributors a rebate for every OxyContin overdose attributable to pills they sold.
The presentation estimated how many customers of companies including CVS and Anthem might overdose. It projected that in 2019, for example, 2,484 CVS customers would either have an overdose or develop an opioid use disorder. A rebate of $14,810 per “event” meant that Purdue would pay CVS $36.8 million that year.
"
- samizdis 6y agoMany thanks; an informative read. FWIW I've just come across a related piece in Jacobin from December 2020: https://jacobinmag.com/2020/12/mckinsey-consulting-firm-opioid-epidemic-purdue-pharma https://jacobinmag.com/2020/12/mckinsey-consulting-firm-opio...
- sjg007 6y agoI mean that logic is just sick and heartless.
- a3n 6y agoSo, they recommended paying distributors to kill people. Because, in addition to the profit distributors would make by merely being in business, they would make even more money for each related death.